Clinical trial

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

NCT07415720

Study summary

ClinicalTrials.gov

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention Artichoke by-product capsules Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Energy-restricted Mediterranean diet (erMeDiet) Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Placebo capsules Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Physical activity Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-05-01

PhaseNA

Conditions

Diabete Type 2unresolved

Obesity & Overweightunresolved

Insulin Resistance Syndromeverified · MONDO: obsolete rare insulin-resistance syndrome

Interventions

Artichoke by-product capsulesDIETARY_SUPPLEMENT

Energy-restricted Mediterranean diet (erMeDiet)BEHAVIORAL

Placebo capsulesDIETARY_SUPPLEMENT

Physical activityBEHAVIORAL

Sponsors & collaborators

Clinica Universidad de Navarra, Universidad de Navarralead sponsor

University of Navarracollaborator

Hospital of Navarracollaborator

Mapped research locations

PamplonaNavarre, Spain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07415720 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.